Position in ALNY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$274,539
-$27,876 QoQ
Shares Held
912
-0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#554
of 780 holders
Holding Since
Dec 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NWAM LLC holds $8,220,053 across 8 Biotechnology names. ALNY ranks #7 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
10,129 | $5,031,378 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,680 | $1,047,547 | |
| 3 | INSM |
INSMED Inc
|
5,071 | $540,670 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
5,530 | $432,833 | |
| 5 | NTLA |
Intellia Therapeutics, Inc.
|
19,540 | $330,616 | |
| 6 | EXEL |
Exelixis, Inc.
|
5,619 | $305,729 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
912 | $274,539 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
3,238 | $256,741 |
All Filings in ALNY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $274,539 | 912 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $302,415 | 914 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $363,452 | 914 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $415,872 | 912 | Shares | Sole | 2026-02-04 | |
| 2025-06-30 | $297,394 | 912 | Shares | Sole | 2026-02-04 | |
| 2025-03-31 | $244,908 | 907 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $213,190 | 906 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $235,425 | 856 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $207,036 | 852 | Shares | Sole | 2024-07-24 | |
| 2022-12-31 | $202,002 | 850 | Shares | Sole | 2023-02-08 | |
| No filing history on record for this holder in this stock. | ||||||